Search for: "ACTAVIS"
Results 441 - 460
of 1,006
Sort by Relevance
|
Sort by Date
12 Oct 2015, 12:11 pm
| IP: When innovation is the answer to a spiritual funk Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs… [read post]
5 Oct 2015, 5:13 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v Warner-Lambert |… [read post]
28 Sep 2015, 3:35 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v Warner-Lambert |… [read post]
25 Sep 2015, 8:17 am
If you think you can get safe harbors, Congress will be the entity to do that after Actavis. [read post]
20 Sep 2015, 4:08 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v Warner-Lambert |… [read post]
15 Sep 2015, 1:39 am
.* BREAKING NEWS Full decision out in the Lyrica case, and it's a whopperDarren breaks the news of the issuance of Mr Justice Arnold's first instance judgement following the full trial in the long-running case of Mylan and Actavis v Warner-Lambert (case management decision here, Court of Appeal decision here and here, and four first instance decisions here, here, here and here).* The debate over "Concussion": Is… [read post]
13 Sep 2015, 9:21 pm
.; Actavis, Inc.; Actavis Pharma, Inc. [read post]
10 Sep 2015, 5:47 pm
Flash forward one hundred or so years and look at the recent Pfizer case in England:From Bloomberg:Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.Judge Richard Arnold issued the rebuke as he ruled that Allergan Plc’s Actavis unit didn’t infringe Pfizer patents with its version of the drug pregalbin.Pfizer… [read post]
10 Sep 2015, 8:32 am
This test requires foreseeability, not intention, on the part of the manufacturer (Actavis), but it also requires intentional administration for the patented indication downstream, and Arnold J found that neither the doctor, nor the pharmacist, had the intention to administer the Actavis product Lecaent for pain.He therefore granted declarations of non-infringement in respect of Actavis, wholesalers of Lecaent, doctors, pharmacists and patients. [read post]
7 Sep 2015, 10:01 am
The lawsuit named Purdue Pharma (maker of OxyContin), Teva Pharmaceutical Industries, Janssen Pharmaceuticals – a subsidiary of Johnson & Johnson, Endo Health Solutions, and Actavis, as well as affiliated companies.One reason why the lawsuit was filed is that Purdue, which makes the best-selling painkiller OxyContin, has never gone to trial on a case of OxyContin abuse. [read post]
16 Aug 2015, 7:39 am
True to form, Actavis was the only life sciences company to make the poll with 25 patent actions made against it (so far). [read post]
3 Aug 2015, 5:10 am
Pick one of those and it will surely work (albeit it would be a mere arbitrary, non-inventive selection of the type discussed in Actavis v Novartis [2010]). [read post]
31 Jul 2015, 4:24 am
The mysteries of the patentability of a substance that already has one known medical use, one a further medical use is found for it, have been recently addressed in numerous Katposts on the litigation in England and Wales between Warner-Lambert and Actavis, most recently here and here. [read post]
27 Jul 2015, 9:35 am
| The IPKat and his friends | GO Outdoors Ltd v Skechers USA Inc II | Allfiled UK Ltd v Eltis & 16 Others | OAEE 'victims' mark in Greece | Icons, flags and the Hazzards of intellectual property toxicity | Why Finland is not Silicon Valley | The Sofa Workshop Ltd v Sofaworks Ltd | The Ukulele Orchestra of Great Britain v Clausen & Another (t/a the United Kingdom Ukulele Orchestra) | Sony/ATV Music Publishing LLC & Another v WPMC Ltd… [read post]
20 Jul 2015, 2:43 am
| The IPKat and his friends | GO Outdoors Ltd v Skechers USA Inc II | Allfiled UK Ltd v Eltis & 16 Others | OAEE 'victims' mark in Greece | Icons, flags and the Hazzards of intellectual property toxicity | Why Finland is not Silicon Valley | The Sofa Workshop Ltd v Sofaworks Ltd | The Ukulele Orchestra of Great Britain v Clausen & Another (t/a the United Kingdom Ukulele Orchestra) | Sony/ATV Music Publishing LLC & Another v WPMC Ltd… [read post]
17 Jul 2015, 8:45 am
McEwan, Joseph Saveri Law Firm describe Deactivating Actavis: The Clash between the Supreme Court and (Some) Lower Courts. [read post]
13 Jul 2015, 3:51 am
| The IPKat and his friends | GO Outdoors Ltd v Skechers USA Inc II | Allfiled UK Ltd v Eltis & 16 Others | OAEE 'victims' mark in Greece | Icons, flags and the Hazzards of intellectual property toxicity | Why Finland is not Silicon Valley | The Sofa Workshop Ltd v Sofaworks Ltd | The Ukulele Orchestra of Great Britain v Clausen & Another (t/a the United Kingdom Ukulele Orchestra) | Sony/ATV Music Publishing LLC & Another v WPMC Ltd… [read post]
10 Jul 2015, 4:22 am
Product hopping was recently in the news with New York state's antitrust suit against Actavis for its decision to withdraw Namenda IR, its 2x/day Alzheimer's drug (with patent protection ending July 2015), to force patients to switch to Namenda XR, a 1x/day version (with patent protection until 2029). [read post]
7 Jul 2015, 1:58 am
No, justsecond medical use ...The sudden return to the headlines of problems relating to second medical use patents, both on last year's AIPPI agenda and in Warner-Lambert's mega-litigation with Actavis over pregabalin [see eg the hugely popular Katposts by Darren, Annsley and even Jeremy here, here, here, here and here] pretty well guaranteed that this issue would feature on this year's programme (incidentally, this is the substantive legal issue that has attracted… [read post]
6 Jul 2015, 12:36 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 52 [week ending on Sunday 14 June] - EU TM reform | Motivate Publishing FZ LLC and another v Hello Ltd | EPO’s Inventor of the Year: poll results | New network for new IP people | Delfi v Estonia | UPC fees | Smith & Nephew Plc v ConvaTec Technologies Inc | Canary Wharf Group Ltd v Comptroller General of Patents, Designs and Trade Marks | Actavis v… [read post]
